Imagion Biosystems Limited wishes to advise that its Australian registered office address has changed with immediate effect to:
c/o K&L Gates, Level 25, 525 Collins Street, Melbourne, Victoria, 3000
The Company’s phone contact details remain unchanged.
Read the Change of Registered Address notice.
We are excited to announce that Imagion Biosystems (ASX: IBX) will be attending two premier medical conferences this fall: the Radiological Society of North
FDA Submission of IND for MagSense® HER2 Phase 2 Clinical Trial on Track Q4 2025 Key Highlights: Wayne State University Collaboration Program Delivers Positive and
Video transcript: Advances in treatment for cancer have greatly improved survivability when the cancer is caught early. However, despite global spending of over $100
We’re on a mission to make cancer more detectable.